Refine by
Genomics Data Articles & Analysis
28 articles found
As the field advances, integrating BCL2 protein mechanisms with genomic and proteomic data may help develop next-generation therapeutics that are both more effective and more precise. ...
Clinical trials are the backbone of modern medicine, responsible for bringing innovative, safe, and efficient treatments to market after rigorous testing and evaluation. However, the conventional process of conducting these trials has often been long, expensive, and fraught with inefficiencies¹. The advent of predictive analytics is reshaping the landscape of clinical trials, ushering in a ...
Submission of sequence data to NCBI archives Next-generation sequencing, PacBio SMRT sequencing, and Nanopore sequencing, can generate numerous sequence data in a single run. ...
AI also plays a pivotal role in the development of gene therapies. By analyzing vast amounts of genomic data, AI algorithms can identify potential genetic targets for therapeutic intervention. ...
In response to the emerging needs in global healthcare, SOPHiA GENETICS has just revealed the New Generation SOPHiA DDM™ Platform, aiming to stay at the forefront of precision medicine and address today the healthcare needs of tomorrow. ...
AI also plays a pivotal role in the development of gene therapies. By analyzing vast amounts of genomic data, AI algorithms can identify potential genetic targets for therapeutic intervention. ...
Goal Understanding of Coronavirus (SARS-CoV-2) of interest using whole-genome sequence data from NCBI Solution Loci helps the scientists to understand the Coronavirus at the molecular level with a few click ...
(6) Plant Biology: Ribo-seq services are pivotal in studying how plants adapt to various growth conditions and environmental stressors, deepening our understanding of gene expression in plants. As the trusted partner in genomics research, CD Genomics is committed to providing high-quality Ribosome Profiling services marked by: Cutting-Edge Technology: ...
With the development of genomic technology, researchers have found that a single reference genome can no longer meet the needs of genomic data analysis, and more and more species, including the human genome, are choosing to construct a pan-genome instead of a single reference ...
Cancer is a heterogenous mixture of diseases characterized by, among other things, the abnormal, uncontrolled growth of cells derived from otherwise healthy tissues (Hanahan 2022). Although cancer cells sometimes grow into balls of cells and stop there (so-called benign tumors), often they gain the ability to disperse throughout the body, seed the growth of other tumors, disrupt the function of a ...
Metagenomics is the culture-independent genomic research of microbial communities. Metagenomics presents a powerful tool to study prokaryotes and viruses in the environment via the analysis of their DNA obtained directly from environmental samples. ...
The high-throughput detection of gene expression relies on next generation sequencing technologies to assess the level of expression of all genes in the genome. These technologies have revolutionized transcriptomic research and we are now entering the ultra-high-throughput era of gene expression studies. ...
Metagenomics is the culture-independent genomic research of microbial communities. Metagenomics presents a powerful tool to study prokaryotes and viruses in the environment via the analysis of their DNA obtained directly from environmental samples. ...
We are excited to announce a beta release of our Calypso tool on the latest Phase II Undiagnosed Diseases Network (UDN) data. This is a project performed in collaboration with the UDN, and we encourage our initial set of UDN investigators to trial this release and provide any feedback, comments, questions or requests to info@frameshit.io. ...
In addition, the weakness of NGS is not conducive to later genome splicing and downstream data analysis, with an average read length of 100-150 bp. ...
Following his successes in CRM, Brian held roles as General Manager and Senior Vice President for Veeva’s Clinical Data Management (EDC) and Safety product lines, where he oversaw the organisation’s internal operations and drove global market engagement for the new business units he instituted, laying the foundation for their strategy, sales, products and services. ...
ByLifebit
Introduction Since the completion of the Human Genome Project, genomics has played an increasingly critical role in the biomedical field. ...
The platform will deliver a next-generation computational infrastructure within Denmark's on-premise supercomputing center, allowing the NGC to meet its vision of establishing and operating a state-of-the-art national infrastructure for personalised medicine while keeping the data at all times in the secure national infrastructure. Only Lifebit with both its ...
ByLifebit
Many ambitious initiatives have been successfully launched around the globe to gather genomic data at scale. The 100,000 Genomes Project has been a turning point for bringing evidence-based precision medicine to life. Over the past 15 years, many cancer treatments have benefited from deploying such population genomics ...
ByLifebit
Genome initiatives spearheaded by burgeoning numbers of data custodians such as Genomics England (GEL), a Lifebit customer, leverage technological advances to amass large volumes of patient data. ...
ByLifebit